A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

NCT07028697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: Daridorexant
DRUG: Placebo

Sponsor

Nxera Pharma Korea Co., Ltd.